A new market study reveals a significant growth forecast for the global Epigenetics-Based Therapeutics Market The market, valued at USD 1.76 billion in 2024, is expected to reach USD 5.17 billion by 2032, demonstrating a Compound Annual Growth Rate (CAGR) of 14.40% during the forecast period. This remarkable expansion is driven by a deeper understanding of epigenetic mechanisms and th... https://www.databridgemarketresearch.com/